BersonSAYalowRSAurbachGDPottsJT. Immunoassay of bovine and human parathyroid hormone. Proc Nat Acad Sci USA1963; 49; 613–17.
2.
ZullJELevNB. A theoretical study of the structure of parathyroid hormone. Proc Natl Acad Sci1980; 77: 3791–5.
3.
KeutmannHT. Trends in parathyroid hormone structure and function. In: CooperCW, ed. Current Research on Calcium Regulating Hormones, Austin: University of Texas Press, 1987: 57–63.
4.
FiskinAMCohnDMPetersonGS. A model for the structure of bovine parathormone derived by dark field electron microscopy. J Biol Chem1977; 252: 8261–8.
5.
RosenblattM.Structure-activity relations in the calcium-reglating peptide hormones. In: ParsonsJA, ed. Endocrinology of Calcium Metabolism. New York: Raven Press, 103–42.
6.
RaoLGMurrayTM. Binding of intact parathyroid hormone to rat osteosarcoma cells: Major contribution of binding sites for the carboxyl-terminal region of the hormone. Endocrinology1985; 117: 1632–8.
7.
PottsJTJrKronenbergHMRosenblattM.Parathyroid hormone chemistry, biosynthesis and mode of action. Adv Protein Chem1982; 15: 323–96.
8.
MorrisseyJJHamiltonJWMacGregorRRCohnDV. The secretion of parathormone fragments 34–84 and 37–84 by dispersed porcine parathyroid cells. Endocrinology1980; 107: 164–71.
9.
MayerGPKeatonJAHurstJGHabenerJF. Effects of plasma calcium concentration on the relative proportion of hormone and carboxyl fragments in parathyroid venous blood. Endocrinology1979; 104: 1778–84.
10.
CohnDVEltingJJFrickMEldeR.Selective localisation of parathyroid secretory protein-I/Adrenal medulla chromogranin A protein family in a wide variety of endocrine cells in the rat. Endocrinology1984; 114: 1963–74.
11.
O'ConnorDTDeftosLJ. Secretion of chromogranin A by peptide-producing endocrine neoplasms. New Eng J Med1986; 314: 1145–51.
HabenerJFPottsJTJr.Relative effectiveness of magnesium and calcium on secretion and biosynthesis of parathyroid hormone in vitro. Endocrinology1970; 98: 197–204.
14.
SilverJRussellJSherwoodLM. Regulation by vitamin D metabolites of messenger RNA for preproparathyroid hormone in isolated bovine parathyroid cells. Proc Natl Acad Sci USA1985; 82: 4270–3.
15.
MartinKJHouskaKAFrietagJJKlahrSSlatopolskyK.The peripheral metabolism of parathyroid hormone. N Eng J Med1979; 301: 1092–8.
16.
CalvoMSFryerMJLaaksoKJStructural requirements for parathyroid hormone action in mature bone. Effects on release of cyclic AMP and bone gamma-carboxyl glutamic acid containing protein from perfused rat hindquarters. J Clin Invest1985; 76: 2348–54.
17.
ZondekHPetowHSiebertW.Die Bedeutung der Calcium-bestimmung im Blute fur die Diagnose der Nierreninsuffizientz. Z Klin Med1923; 99: 129–34.
18.
AlbrightF.Case records of the Massachusetts General Hospital (Case 27461). New Eng J Med1941; 225: 789–92.
19.
YoshimotoKYamasakiRSakaiHEctopic production of parathyroid hormone by small cell lung cancer in a patient with hypercalcaemia. J Clin Endocrinol Metab1989; 68: 976–81.
20.
GodsallJWBurtisWJInsognaKLBroadusAEStewardAF. Nephrogenous cyclic AMP, adenylate cyclase stimulating activity and the humoral hypercalcaemia of malignancy. Rec Prog Horm Res1986; 40: 705–50.
21.
BurtisWWuTBenchCIdentification of a novel 17000 dalton parathyroid hormone-like adenylate cyclase-stimulating protein from a tumor associated with humoral hypercalcaemia of malignancy. J Biol Chem1987; 262: 7151–6.
22.
MoseleyJMKubotaMDiefenbach-JaggerHParathyroid hormone related protein purified from a human lung cancer cell line. Proc Natl Acad Sci USA1987; 84: 5048–52.
23.
StrewlerGJSternPHJacobsJWA parathyroid hormone-like protein from human renal carcinoma cells: Structural and functional homology with parathyroid hormone. J Clin Invest1987; 80: 1803–7.
24.
InsognaKL. Humoral hypercalcemia of malignancy—the role of parathyroid hormone-related protein. In: MarcusR, ed. Endocrinology and Metabolism Clinics of North America: Hypercalcaemia, Vol 18, USA: WB Saunders, 1989: 779–94.
25.
IngleARBaileyJEMatthewsHLHarropJS. Performance and clinical utility of a commercially available ‘C-terminal’ PTH assay. Ann Clin Biochem1986; 23: 434–9.
26.
RobertsonWRLambertALoveridgeN.The role of modern bioassays in clinical endocrinology. Clin Endocrinol1987; 27: 259–78.
27.
NissensonRAAbbotSRTeitelbaumAPClarkOHArnaudCD. Endogenous biologically active human parathyroid hormone: Measurement by guanyl nucleotide-amplified adenylate cyclase assay. J Clin Endocrinol Metab1981; 46: 604–12.
28.
SeshadriMSChanYLWilkinsonMRMasonRSPosenS.Some problems associated with adenylate cyclase bioassays for parathyroid hormone. Clin Sci1985; 68: 311–19.
29.
NiepelBRadekeHAtkinsonMJJuppnerHHeschRD. A homologous biological probe for parathyroid hormone in human serum. J Immunoassay1983; 4: 21–7.
30.
KleeGGPreissnerCMSchloegelIWKaoPC. Bioassay of parathyrin: Analytical characteristics and clinical performance in patients with hypercalcaemia. Clin Chem1988; 34: 482–8.
31.
ChambersDJDunhamJZanelliJMParsonsJABitenskiLChayenJ.A sensitive bioassay of parathyroid hormone in plasma. Clin Endocrinol1978; 9: 375–9.
32.
BroadusAEMahaffeyJEBartterFCNeerRM. Nephrogenous cyclic adenosine monophosphate as a parathyroid function test. J Clin Invest1977; 60: 771–83.
33.
MalletteLE. Sensitivity of the anti-bovine parathyroid serum 211/32 to synthetic fragments of human parathyroid hormone. J Clin Endocrinol Metab1980; 50: 201–3.
34.
EndresDBVillanuevaRSharpCFJrSingerFR. Measurement of parathyroid hormone. In: MarcusR, ed. Endocrinology and Metabolism Climcs of North America: Hypercalcaemia, Vol 18. USA: WB Saunders, 1989; 611–29.
35.
EkinsRPDakubuS.The development of high sensitivity pulsed light time—resolved fluoroimmunoassays. Pure Appl Chem1985; 57: 473–82.
36.
WoodheadJSWeeksI.Circulating thyrotropin as an index of thyroid function. Ann Clin Biochem1985; 22: 455–9.
37.
NewmanDJAshbyJP. Clinical and laboratory evaluation of a two-site immunoradiometric assay for intact parathyroid hormone. Ann Clin Biochem1988; 25: 654–60.
38.
BrownRCAstonJPWeeksIWoodheadJS. Circulating intact parathyroid hormone measured by a two-site immunochemiluminometric assay. J Clin Endocrinol Metab1987; 65: 407–14.
39.
HackengWHLLipsPNetelenbosJCLipsCJM. Clinical implications of estimation of intact parathyroid hormone (PTH) versus total immunoreactive PTH in normal subjects and hyperparathyroid patients. J Clin Endocrinol Metab1986; 63: 447–53.
40.
NussbaumSRZahradnikRJLavigneJRHighly sensitive two-site immunoradiometric assay of parathyrin and its clinical utility in evaluating patients with hypercalcemia. Clin Chem1987; 33: 1364–7.
41.
BlindESchmidt-GaykHScharlaSTwo-site assay of intact parathyroid hormone in the investigation of primary hyperparathyroidism and other disorders of calcium metabolism compared with a mid-region assay. J Clin Endocrinol Metab1988; 67: 353–60.
FrolichMWalmaSTPaulsonCPapadopoulosSE. Immunoradiometric assay for intact human parathyroid hormone: Characteristics, clinical application and comparison with a radioimmunoassay. Ann Clin Biochem1990; 27: 69–72.
45.
RaiszLGYajnikCHBockmanRSBowerBF. Comparison of commercially available parathyroid hormone immunoassays in the differential diagnosis of hypercalcaemia due to primary hyperparathyroidism or malignancy. Ann Int Med1979; 92: 739–40.
46.
MalletteLETumaSNBergerREKirklandJL. Radioimmunoassay for the middle region of human parathyroid hormone using an homologous antiserum with a carboxy terminal fragment of bovine parathyroid hormone as radioligand. J Clin Endocrinol Metab1982; 54: 1017–24.
47.
AshbyJPThakkarH.Diagnostic limitations of region-specific parathyroid hormone assays in the investigation of hypercalcaemia. Ann Clin Biochem1988; 25: 275–9.
48.
WoodheadJS. The measurement of circulating parathyroid hormone. Clin Biochem1990; 23: 17–21.
49.
RyanMFJonesSRBarnesAD. Modification to a commercial immunometric assay permitting intraoperative monitoring of parathyroid hormone levels. Ann Clin Biochem1990; 22: 65–8.
50.
GunnIRHalkettJM. Rapid accurate diagnosis of acute hyperparathyroid crisis. Lancet1989; ii: 618–19.
51.
AshbyJPNewmanDJRinslerMG. Is intact PTH a sensitive biochemical indicator of deranged calcium homeostasis in vitamin D deficiency. Ann Clin Biochem1989; 26: 324–7.
52.
CurleyIRWheelerMHAstonJPBrownRCWeeksIWoodheadJS. Studies in patients with hyperparathyroidism using a new two-site immunochemiluminometric assay for circulating intact (1–84) parathyroid hormone. Surgery1989; 102: 927–31.
53.
LogueFCFraserWDO'ReillyDSt JBeastallGH. The circadian rhythm of PTH (1–84) and nephrogenous cyclic adenosine monophosphate in normal men. J Endocrinol1989; 121: R1–3.
54.
LogueFCFraserWDGallagherSJO'ReillyDSt JBeastallGHBogleIT. Loss of circadian rhythm of PTH (1–84) and nephrogenous cyclic adenosine monophosphate in hyperparathyroidism. Clin Endocrinol1990; 32: 475–83.
55.
LogueFCBeastallGHFraserWDO'ReillyDSt J. Intact parathyroid hormone assays: Interpretation must take account of biological variation. BMJ1990; 300: 210–11.
56.
KitamuraNShigenoCShiomiKEpisodic fluctuation in serum intact parathyroid hormone concentration in men. J Clin Endocrinol Metab1990; 70: 252–63.
57.
HarmsH-MKaptainaUKulpmanW-RBrabantGHeschRD. Pulse amplitude and frequency modulation of parathyroid hormone in plasma. J Clin Endocrinol Metab1989; 69: 843–51.
58.
HendersonSAGrahamHKMollanRABRiddochCSheridanBJohnsonH.Calcium homeostasis and exercise. Int Orthopaedics (SICOT)1989; 13: 69–73.
59.
SeelyEWMooreTJLebottMSBrownEM. A single dose of lithium carbonate acutely elevates intact parathyroid hormone levels in humans. Acta Endocrinol (Copenh)1989; 121: 174–6.
60.
MalletteLEKhouriKZengotitaHHollisBWMaliniS.Lithium treatment increases intact and midregion parathyroid hormone and parathyroid volume. J Clin Endocrinol Metab1989; 68: 654–60.
61.
ElmgreenJTougaardLLethAChristensenMS. Elevated serum parathyroid hormone concentration during treatment with high ceiling diuretics. Eur J Clin Pharmacol1980; 18: 363–4.
62.
CompstonJESilverACCroucherPIBrownRCWoodheadJS. Elevated serum intact parathyroid hormone levels in elderly patients with hip fracture. Clin Endocrinol1989; 31: 667–72.
63.
SokollLJMorrowFDQuirbachDMDawson-HughesB.Intact parathyrin in postmenopausal women. Clin Chem1988; 34: 407–10.
64.
DavisOKHawkinsDSRubinLPPostillicoJTBrownEMSchiffI.Serum parathyroid hormone (PTH) in pregnant women determined by an immunoradiometric assay for intact PTH. J Clin Endocrinol Metab1988; 67: 850–2.
65.
AshbyJPLoveridgeNBrownRCZanelliJMRinslerGWattsRWE. Anomalies in the assay of parathyroid hormone in normocalcaemic patients with renal stone disease. Clin Endocrinol1988; 29: 131–40.
66.
GrobbeeDEHackengWHLBirkenhagerJCHofmanA.Raised plasma intact parathyroid hormone concentrations in young people with mildly raised blood pressure. BMJ1988; 296: 814–16.
67.
AddisonGMHalesCNWoodheadJSO'RiordanJLH. Immunoradiometric assay of parathyroid hormone. J Endocrinol1971; 49: 521–30.
68.
LogueFCPerryBChapmanRSMilneIJamesKBeastallGH. A two-site immunometric assay for PTH (1–84) using N and C terminal specific monoclonal antibodies. Ann Clin Biochem1991; 28: 160–6.
69.
LundbergPALindstedtGJanssonSTisellLE. Assay of intact parathyrin in the immediate and long-term post operative follow-up of patients treated for hyperparathyroidism or thyroid tumour. Clin Chem1989; 35: 340–1.